164 related articles for article (PubMed ID: 15006934)
1. No more equivalence trials for antibiotics in exacerbations of COPD, please.
Miravitlles M; Torres A
Chest; 2004 Mar; 125(3):811-3. PubMed ID: 15006934
[No Abstract] [Full Text] [Related]
2. Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2007; 2(3):191-204. PubMed ID: 18229559
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Llor C; Naberan K; Cots JM; Molina J; Miravitlles M
Int J Clin Pract; 2004 Oct; 58(10):937-44. PubMed ID: 15587773
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly.
Boersma WG
Eur Respir J; 2012 Jul; 40(1):1-3. PubMed ID: 22753830
[No Abstract] [Full Text] [Related]
6. Moxifloxacin: a respiratory fluoroquinolone.
Miravitlles M; Anzueto A
Expert Opin Pharmacother; 2008 Jul; 9(10):1755-72. PubMed ID: 18570608
[TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
[TBL] [Abstract][Full Text] [Related]
8. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
9. The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
Wilson R; Macklin-Doherty A
Expert Rev Respir Med; 2012 Nov; 6(5):481-92. PubMed ID: 23113693
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI).
Chuchalin A; Zakharova M; Dokic D; Tokić M; Marschall HP; Petri T
BMC Pulm Med; 2013 Jan; 13():5. PubMed ID: 23343427
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
Miravitlles M; Anzueto A; Ewig S; Legnani D; Stauch K
Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
[TBL] [Abstract][Full Text] [Related]
12. [Acute exacerbated chronic bronchitis. Antibiotics in comparison].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603610
[No Abstract] [Full Text] [Related]
13. [Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].
Miravitlles M; Molina J; Brosa M
Arch Bronconeumol; 2007 Jan; 43(1):22-8. PubMed ID: 17257560
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
[TBL] [Abstract][Full Text] [Related]
15. Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.
Miravitlles M; Llor C
Clin Drug Investig; 2007; 27(2):95-104. PubMed ID: 17217314
[TBL] [Abstract][Full Text] [Related]
16. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Faragó G; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2011; 6():373-83. PubMed ID: 21760724
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Sethi S
Eur Respir J; 2012 Jul; 40(1):17-27. PubMed ID: 22135277
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin: a review of its use in the management of bacterial infections.
Keating GM; Scott LJ
Drugs; 2004; 64(20):2347-77. PubMed ID: 15456331
[TBL] [Abstract][Full Text] [Related]
19. A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin.
Simoens S; Decramer M
Expert Opin Pharmacother; 2008 Jul; 9(10):1735-44. PubMed ID: 18570606
[TBL] [Abstract][Full Text] [Related]
20. [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
Iudina LV; Snezhko VI; Rachko IuV
Lik Sprava; 2004; (1):34-7. PubMed ID: 17051710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]